Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia

Autor: Mayo, Michele *, Chutake, Yogesh *, Karnik, Rahul *, McDonald, Alice *, Cho, Patricia S. *, Filiatrault, Jessica *, Chen, Dapeng *, Dixit, Vaishali *, Proctor, William *, Breitkopf, Susanne *, Qi, Frank *, Hu, Kan-Nian *, Sharma, Kirti *, Ewesuedo, Reggie *, Weiss, Matt *, Growney, Joseph D. *, Williams, Juliet *, Schalm, Stefanie S *
Zdroj: In Blood 15 November 2022 140 Supplement 1:6239-6240
Databáze: ScienceDirect